Home
overview

SMi's premier 11th Annual Parallel Trade for Pharma returns to London on 6-7 Feb 2017 after 10 successful years in the running!

According to the European Federation of Pharmaceutical Industries and Associations, parallel trade was estimated to amount to € 5,589 million (value at ex–factory prices) in 2014. The fragmentation of the EU pharmaceutical market has resulted in a lucrative year for parallel trade.  Factors such as foreign exchange fluctuations and  legal battles on trademarks and counterfeit medicines are continuously shifting the European market dynamics.

With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? This event will discuss short term versus long term concerns of pharma manufacturers, regulators, as well as parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges. Discussion topics include:

  • Parallel Trade 101 - Which factors determine the flow of pharmaceutical products in Europe?
  • The European Commission’s Falsified Medicines Directive – recent updates
  • Panel Debate – In the spotlight: Shortages
  • The Patient’s perspective
  • Parallel traders panel – challenges and opportunities
  • Beyond pharmaceutical products – parallel imports of medical devices
  • Panel Debate - In the spotlight: Technology & new trends
  • Regional and country focus - Scandinavia, Germany, the UK, Central and  Eastern Europe, Turkey and Eurasia

This is the only industry meeting with 80+ selected senior leaders in parallel trade to discuss upcoming trends and share best practices. Join us today to keep abreast and stay ahead of competition!
 

This conference will enable you to:
•Update on parallel trade regulations to ensure compliance
•Recap on regional markets' parallel trade activities and outlooks
•Reassess and benchmark your supply chain and distribution model against peers' for best practice
•Understand the rationale and strategy of parallel distributors through case studies and panel discussions
•Network and interact with senior thought leaders to discuss common challenges and share experiences
 

Who Should Attend?

VPs, Directors, Heads, Chiefs, Principals, Managers of:
Parallel Trade/ Import/ Export
Distribution
Supply Chain Management/ Planning
General Counsel
Legal
Market Access
Business Planning
Pricing
Finance
Procurement
Sales
Regulatory/ Public Affairs

from pharmaceutical and biotechs, drug manufacturers, pharmaceutical wholesalers, pharmacies, pharmaceutical importers and exporters, parallel traders, medical device, regulator and academics.

 

Abbott Laboratories Limited; Agency for Medicinal Products and Medical Devices of the Republic of Slovenia; Allergan Limited; Amgen; Amgen; Arnold and Porter; Astellas Pharma Europe; AstraZeneca; Bayer Healthcare; Biogen Idec; Biopharm Insight; Boehringer-Ingelheim; Bulmar ML Ltd; Chiesi Farmaceutici SpA; Delfarma; EY; Europe Economics; European Alliance for Access to Safe Medicines; European Association of Euro-Pharmaceutical Companies; Galderma; German Pharmaceutical Industry Association; Gilead Sciences Ltd; Grunenthal Gmbh; IGES Institut.; IMS Health; Kantar Health; LEO Pharma A/S; McKesson Global Procurement & Sourcing Limited; McKesson Pharmaceutical; MD Pharma SA; Merck Sharp and Dohme Israel; MHRA; MPA Business Services Ltd; MPCC Global Regulatory Solutions; Mundipharma ;NOVARTIS; Novo Nordisk Pharma AG; Otsuka Pharmaceutical Europe Ltd; Preglem/ Gedeon Richter; Quintiles (UK) Ltd; Ratiopharm GmbH; Sanofi Pasteur MSD; Shire Pharmaceuticals Group Plc; Smith & Nephew; Teva Pharmaceuticals Europe BV; The National Pharmaceutical Association Ltd; UCB Pharma and many more!
 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Eric Noehrenberg

Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc

9:10 OPENING ADDRESS: Parallel Trade 101 - Which factors determine the flow of pharmaceutical products in Europe?

Eric Noehrenberg

Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc

 

  • Parallel exports and parallel imports – defining the terms
  • Beyond price differences and legal guidelines – currency fluctuations and much more
  • Parallel trade in the EU – key facts including value, key import and source markets as well as key players
  • Impact on patients – shortages and quality
  • Current trends with parallel trade in pharmaceuticals in Europe
  • 9:50 The European Commission’s Falsified Medicines Directive – recent updates

    Richard Greville

    Richard Greville, Director Wales and Director Distribution & Supply, The Association of the British Pharmaceutical Industry

  • Exploring the legal framework of the Falsified Medicines Directive
  • What progress has been made since February 2016?
  • Implementation of the Falsified Medicines Directive - the new rules on medicine verification
  • All what you need to know about  "product information templates”
  • What are the regulatory requirements for nationally authorised products?
  • 10:30 Morning Coffee

    11:00 Initiatives of Parallel Distributors in the context of Falsified Medicines Directive

    Tomasz Dzitko

    Tomasz Dzitko, President, Delfarma

  • Good Parallel Distribution Guidelines
  • Early Warning Anti-CF Platform
  • Joint Audits Initiative
  • European Medicines Verification Organization
  • 11:40 European Medicines Verification Organization – an update from Brussels

    Heinz Kobelt

    Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies

  • Explaining the complexity behind the planning and design of a pan-European medicine verification system
  • Implementing national verification systems that function at an equal level of efficacy, are interoperable and cost effective
  • The role of the European Hub and national data repositories
  • EMVO and interactions with various supply chain stakeholders
  • 12:20 Networking Lunch

    13:30 Panel Debate – In the spotlight: Shortages

  • Shortages explained – manufacturing and trade related shortages
  • The implications of parallel trade for low-price countries
  • When Governments need to intervene – Bulgaria’s case – oncology drugs
  • Examining an increased tendency to yield new medicines’ availability in low income countries
  • Overcoming the challenges – on the road to a more transparent and regulated distribution cycle
  • Will new potential trade barriers eliminate the shortages problem?
  • Impact of possible import of products from outside the EU into the EU
  • Tomasz Dzitko

    Tomasz Dzitko, President, Delfarma

    Heinz Kobelt

    Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies

    14:10 Country focus: Germany – the changing dynamics

    14:50 Northern Europe – opportunities and challenges

    Flemming  Wagner

    Flemming Wagner, CEO, Abacus Medicine

  • An overview of latest developments in parallel trade in Northern Europe (including Scandinavia)
  • Parallel trade – what does the future hold?
  •  The benefits of parallel trade for the European society
  • Future threats to parallel trade
  • 15:30 Afternoon Tea

    15:50 Region focus: Eurasia

    Alexey Savin

    Alexey Savin, Principal Russia and CIS, IMS Health

  • Exploring regulatory aspects in Eurasia
  • Focus on Russia – reviewing the status after the recent legalisation of parallel trade
  • Azerbaijan as a regional hub
     
  • 16:30 Legal 101 - IP, competition and regulatory law

  • The impact of IP on parallel trade of pharmaceuticals
  • The competition restrictions on dual pricing, quota and DTP models
  •  How does the regulatory system deal with parallel trade?
     
  • Kathy Osgerby

    Kathy Osgerby, Associate, Arnold & Porter

    Karoline Zwierzynska

    Karoline Zwierzynska, Associate, Arnold & Porter

    17:10 Chairman's Closing Remarks and Close of Day One

    9:00 Chairman's Opening Remarks

    Eric Noehrenberg

    Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc

    9:10 PANEL DEBATE: The big question - what will Brexit mean for parallel trade to and from the UK?

    Andrew Stainthorpe

    Andrew Stainthorpe, Director Market Access and Managed Entry, Research Health

  • Will a post-Brexit UK need a new trade deal with the European Union? The impact of tariffs under a new trade deal
  • How can wholesalers tackle the uncertainty until trading arrangements are finalized?
  • How are the new circumstances affecting medicine supplies in the UK and the rest of Europe? The impact of currency fluctuations and a weaker pound
  • Short term concerns versus long term concerns
  • What can the UK learn from Switzerland and Norway?
  • 9:50 European parallel trade – past, present and future

    Shabnam Hanassab

    Shabnam Hanassab, Senior Consultant, IMS Health

  • Key trends and dynamics in distribution and dispensing
  • Outlook and key factors likely to influence the market going forward
     
  • 10:30 Morning Coffee

    10:50 The case against parallel trade in the EU – will the UK end parallel trade

    Dermot Glynn

    Dermot Glynn, Senior Advisor, Europe Economics

  • Patented pharmaceuticals are not like widgets
  • Parallel trade is wasteful and does no good
  • Parallel trade prevents poor people from being treated with the best medicines
  • 11:30 Parallel traders panel – challenges and opportunities

  • How traders can work together to improve supply chain safety – unleashing the potential of collaboration
  • Strategies for overcoming the threat to patients posed by counterfeit drugs - the role of traders in ensuring product quality and safety
  • An overview of initiatives in the context of Falsified Medicines Directive
     
  • Flemming  Wagner

    Flemming Wagner, CEO, Abacus Medicine

    Maarten Kamphuis

    Maarten Kamphuis, Business Development Director, FisherFarma

    12:20 Networking Lunch

    13:30 Beyond pharmaceutical products – parallel imports of medical devices

    Katarzyna Kolasa

    Katarzyna Kolasa, Science Ph.D, Warsaw Medical University

  • Benchmarking market conditions for medical devices with pharmaceutical products
  • Recent regulations and guidelines for parallel importers of medical devices
  • What pharmaceutical companies can learn from medical devices manufacturers?
  • 14:10 Fighting fakes by raising public awareness – how to change consumer behaviours

    Mike Isles

    Mike Isles, Executive Director, European Alliance for Access to Safe Medicines

  • An overview of statistical trends and the rising threat
  • What are the most efficient ways to address the safety and legitimacy of websites selling medicines
  • The power of educational websites – convincing results that raising consumer awareness can change behaviours
  • What organisations actively collaborate to enhance patient safety and how can you get involved
  • 14:50 Managed entry schemes, HTA and parallel trade

    Andrew Stainthorpe

    Andrew Stainthorpe, Director Market Access and Managed Entry, Research Health

  • Managed entry arrangements are becoming the norm for high cost drugs
  • How schemes are tailored to each market -  including national, regional and local arrangements
  • Significant price differences and the potential for parallel trading
  • Exploring available mechanisms to address risks
  • 15:30 Afternoon Tea

    16:00 Recap of the 2016 Meeting - Ask the Panel and Audience

    Eric Noehrenberg

    Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc

    Delegates will have the final chance to ask speakers and colleagues plus summing up what they’ve learnt over the 2-day meeting. It’ll be a recap for objectives set on Day 1 and sharing of key takeaways.

    16:30 Chairman’s Closing Remarks and Close of Day Two

    +

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.